<DOC>
	<DOCNO>NCT02844023</DOCNO>
	<brief_summary>Giant cell arteritis Horton disease vasculitis affect great vessel . This frequent vasculitis population age 50 . This vasculitis origin inflammatory infiltrate arterial tunic , essentially compose lymphocyte . Clinical sign deterioration general state , unusual cephalgias , jaw pain , scalp hyperesthesia , also serious ischemic complication , especially ophthalmologic possibility go blind . Until , standard treatment high dosage corticosteroid therapy . Diagnosis base criterias American College Rheumatology , date back 1990 . The relapse rate important , range 10 64 % accord study . There also issue become dependent steroid . So important determine new diagnosis marker therapeutic follow giant cell arteritis . With study several biomarkers inflammation study order determine one ore many good sensitivity special feature diagnosis follow giant cell arteritis . The main goal determine new diagnosis marker giant cell arteritis .</brief_summary>
	<brief_title>Biomarkers Giant Cells Arteritis</brief_title>
	<detailed_description />
	<mesh_term>Arteritis</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<criteria>Patient suffer giant cell arteritis . Inclusion discovery symptom , relapse . Healthy volunteer Treatment corticosteroid since 8 day patient suffer giant cell arteritis , exept patient corticosteroid polymyalgia rheumatica . Other disease giant cell arteritis could introduce inflammatory symptom , especially tumoral process progress chronic inflammatory disease ( one giant cell arteritis )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Arteritis</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Horton disease</keyword>
</DOC>